Eris Lifesciences Limited on Tuesday posted a standalone net profit of ₹87 crore for the first quarter ended June 2020, as against ₹82 crore recorded in the corresponding quarter a year ago, indicating 6 per cent year-on-year rise.
Its revenues from operations stood at ₹261 crore, as against ₹262 crore.
On consolidated basis, its net profit stood at ₹89 crore, which is about 6 per cent higher than ₹84 crore it recorded in the same quarter last year. The consolidated revenues from operations stood at ₹293 crore for the quarter as against ₹277 crore last year for same quarter.
The board of directors has declared interim dividend of ₹5.50 (at the rate of 550 per cent) on each fully paid-up equity share of ₹1 for the financial year 2020-21.
Company shares ended at ₹510 on Tuesday, down by nearly 6 per cent from previous close on the Bombay Stock Exchange.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.